DarioHealth Studies Show Digital Platform Cuts Hospitalizations, Boosts Weight Loss
Event summary
- Four studies presented at the ADA Scientific Sessions show Dario's platform reduced hospitalizations by 0.23 PPPY among high-risk cardiometabolic patients.
- Dario's digital intervention alone achieved 6.4% weight loss at 12 months, rising to 14.3% when combined with GLP-1 therapy.
- 44.8% of high-risk diabetes users saw at least a 1% eA1c reduction at 12 months with consistent platform engagement.
- 27 studies presented at ADA over eight years support Dario's shift toward claims-based and outcomes-driven payment models.
The big picture
DarioHealth's latest data reinforces the growing trend of digital health platforms moving closer to care, positioning themselves to capture medical spend through measurable outcomes. The company's ability to demonstrate cost savings and improved clinical outcomes across multiple chronic conditions strengthens its case for enterprise buyers looking to consolidate fragmented solutions. This strategic shift aligns with broader industry movements toward value-based care and integrated digital health management.
What we're watching
- Revenue Model Shift
- How quickly Dario can transition to claims-based and outcomes-driven payments from health plans and employers.
- Engagement Sustainability
- Whether Dario can maintain high user engagement levels to drive long-term clinical outcomes.
- Competitive Differentiation
- The pace at which Dario can scale its platform to address multiple chronic conditions within a single integrated solution.